Viewing Study NCT01323803


Ignite Creation Date: 2025-12-24 @ 7:14 PM
Ignite Modification Date: 2025-12-27 @ 3:17 AM
Study NCT ID: NCT01323803
Status: COMPLETED
Last Update Posted: 2017-08-28
First Post: 2011-03-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Eosinophilic Esophagitis Databank
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Overview

Official Title: Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)
Status: COMPLETED
Status Verified Date: 2017-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CoFAR5
Brief Summary: This study will establish a registry for participants with eosinophilic esophagitis (EoE) and create a research resource that will provide further insights into EoE.
Detailed Description: Eosinophilic esophagitis (EoE) is a newly recognized chronic disease that is increasingly being diagnosed in children and adults. Many patients with EoE also have food allergies. EoE is characterized by inflammation and accumulation of a specific type of immune cell, called an eosinophil, in the esophagus. While there have been several large studies of EoE, very few have focused on the roles the immune system, genetics/heredity, and the environment in EoE.

The samples and information collected from participants will help to identify and understand the genetic mechanisms underlying eosinophilic esophagitis.

The Cincinnati Children's Hospital Medical Center will serve as the Central Laboratory for genetic characterization studies.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: